Bonnier Capital has invested up to SEK 350 million in Safe Life, a Swedish company specializing in defibrillators and CPR training, aiming to enhance emergency healthcare solutions.
Information on the Target
Safe Life is a Swedish company established in 2019, specializing in the sale, rental, and monitoring of defibrillators, as well as providing CPR training. With a rapidly expanding presence, Safe Life operates in nine countries across Europe and North America, including Sweden, Finland, the U.K., Canada, and the United States. The company has projected a pro forma turnover of SEK 1.4 billion for the year 2023, highlighting its significant growth and market potential.
Industry Overview in Sweden
The healthcare sector in Sweden is renowned for its advanced medical infrastructure and innovation, making it conducive to investments focused on health-related products and services. Within this sector, the demand for emergency medical services, particularly for cardiac arrest response, has seen an upward trend. As more public places adopt safety measures, the accessibility of defibrillators and trained personnel has become critical.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
In recent years, there has been an increasing emphasis on public health initiatives, driving the growth of automated external defibrillators (AEDs) in non-hospital settings, such as schools,
Similar Deals
Rubicon Healthcare Partners → PeptiSystems
2024
Keensight Capital → Bentley Endovascular Group AB
2023
Frazier Life Sciences → Egetis Therapeutics AB
2023
Priveq Investment → Swemac Innovation AB
2023
Polaris → Distriktstandvården
2023
KKR and Impilo → Immedica Pharma
2023
Bonnier Capital
invested in
Safe Life
in 2023
in a Growth Equity & Expansion Capital deal
Disclosed details
Transaction Size: $39M
Revenue: $132M